Chargement en cours...
Prophylactic administration of recombinant activated factor VII in coronary revascularization surgery
OBJECTIVE: The objective of this clinical trial is to study the effectiveness of administering recombinant activated factor VII (rFVIIa) in reducing the amount of bleeding and the need for homologous blood and products transfusion in cardiac surgical coronary revascularization procedures done under...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Medknow Publications & Media Pvt Ltd
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3757804/ https://ncbi.nlm.nih.gov/pubmed/24015134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1658-354X.115364 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|